AI-generated summary
The authors reviewed 85 patients with midfrontal vascular lesions treated with 595 nm pulsed dye laser between 2018 and 2023. They report a 96.4% total effective rate and a 69.4% cure rate, with no adverse events, and better outcomes in younger patients and pink lesions. The study is a retrospective case series without a control group.
- Participants
- 85
- Who or what was studied
- 85 patients with vascular lesions in the midfrontal area treated with pulsed dye laser between 2018 and 2023
- Wavelengths
- 595 nm
- Limits stated in the abstract
- The abstract describes a case series without a control group, so outcomes cannot be attributed to treatment alone.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 595 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Adverse event. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.